TRANSEURO is a European research consortium with the principal objective to develop an efficacious and safe treatment methodology for Parkinson’s disease suffering patients using fetal cell based treatments. The consortium has gathered international experts including leading clinicians, scientists, industrial partners, ethicists and patients’ representatives who have joined forces in a new round of experimental work and cell therapy trials in Parkinson’s Disease.
This consortium studies the biology of human embryonic stem and induced pluripotent cells and the mechanisms responsible for their differentiation into more specialized cell types. This consortium is developing the tools, techniques, and expertise necessary for eventual medical, pharmaceutical and bioindustrial applications.
EuroSyStem is a European Community funded partnership between Universities, small to medium businesses and named researchers from both the public and private sector.
Its goal is to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells.
The STEM-HD consortium is composed of 7 partner institutions from five European countries. It is a three-year research program, aims to make major contributions to the understanding of the molecular mechanisms of Huntington’s disease as a necessary step towards a cure.
EuroStemCell – the European stem cell portal – brings you a broad spectrum of stem cell information. EuroStemCell has specialized content for researchers, accessible resources for non-scientists and award-winning films. Moreover, it has critical analysis of the latest developments in stem cell research and space for all to have their say: a European stem cell community.
The International Society for Stem Cell Research is an independent, nonprofit organization established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell research and application.
The centre aims to integrate, coordinate and promote research at the University of Milan on the biology of both adult and embryonic stem cells and their possible applications in medicine, pharmacology, toxicology and veterinary use.
The Lighthouse is managed by a team of editors, with the help of a chat room manager, moderators and regular contributors. All are volunteers and Huntington’s disease family members and friends.
Beyond our common experiences, we share a common mission: to present and explain the latest research findings on HD.
The Hereditary Disease Foundation (HDF) aims to cure genetic illness by supporting basic biomedical research. Dr. Milton Wexler started the HDF in 1968 when his wife was diagnosed with Huntington’s disease (HD). The Foundation uses a variety of strategies – workshops, grants, fellowships, and targeted research contracts – to solve the mysteries of genetic disease and develop new treatments and cures.
CHDI is a private, not-for-profit research organization, working with an international network of scientists to discover drugs that slow the progression or delay the onset of HD.
They seek to accelerate scientific progress by serving as a collaborative enabler, encouraging and supporting cooperation and collaboration among HD researchers.
The Society is a National, voluntary health organization dedicated to improving the lives of people with Huntington’s Disease and their families.
The mission of the National Institute for Neurological Disorders and Stroke of NINDS is to reduce the burden of neurological disease – a burden borne by every age group, by every segment of society, by people all over the world. It conducts, fosters, coordinates, and guides research on the causes, prevention, diagnosis, and treatment of neurological disorders and stroke, and supports basic research in related scientific areas.
The European Parkinson’s Disease Association is a non-political, non-religious, and non-profit making organization concerned with the health and welfare of people living with Parkinson’s disease and their families and carers. Founded in June 1992 in Munich, with a membership of nine European Parkinson’s patient organisations, the EPDA currently has a membership of 43 organisations across Europe, see www.epda.eu.com/members.
This is the UK’s Parkinson’s support and research charity. They provide information and support through their UK-wide team of information and support workers.
Useful guidelines for the clinical translation of stem cells and a patient handbook on stem cell therapies.